Order Article Reprints

Manioudaki S, Vasilieva L, Geladari E, Mani I, Athanassa Z, Elefsiniotis I, Hadziyannis E, Sevastianos V, Oikonomou A, Theophilou A, et al. Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. Life. 2025; 15(12):1794. https://doi.org/10.3390/life15121794

Manioudaki, Sofia, Larisa Vasilieva, Eleni Geladari, Iliana Mani, Zoe Athanassa, Ioannis Elefsiniotis, Emilia Hadziyannis, Vasilios Sevastianos, Aikaterini Oikonomou, Andreas Theophilou, and et al. 2025. "Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators" Life 15, no. 12: 1794. https://doi.org/10.3390/life15121794

Manioudaki, S., Vasilieva, L., Geladari, E., Mani, I., Athanassa, Z., Elefsiniotis, I., Hadziyannis, E., Sevastianos, V., Oikonomou, A., Theophilou, A., Diamantea, F., & Alexopoulou, A. (2025). Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. Life, 15(12), 1794. https://doi.org/10.3390/life15121794